Results 121 to 130 of about 56,519 (290)

Exploring Linalool‐Based Phytotherapy for Excitatory/Inhibitory Imbalance in Alzheimer's Disease: A Review of Lavender and Cannabis Therapeutic Effects on Sleep, Seizures, and Cognition

Phytotherapy Research, EarlyView.
Schematic overview of the proposed neuromodulatory actions of linalool in Alzheimer's disease. Through multi‐target effects on oxidative stress, amyloid aggregation, GABAergic and glutamatergic signaling, linalool may restore excitatory/inhibitory balance.
Ilaria Piccialli, Giovanni Roviello, Giorgia Magliocca, Emilia Esposito, Anna Pannaccione   +4 more
wiley   +1 more source

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System. [PDF]

Front Pharmacol, 2022
Pandey M, Jain N, Kanoujia J, Hussain Z, Gorain B.   +4 more
europepmc   +1 more source

Association between antipsychotic agents and risk of lung cancer: a nested case-control study. [PDF]

Cancer Commun (Lond), 2022
Li J, Tang F, Si S, Xue F.
europepmc   +1 more source

Insights from a 6‐year hair drug analysis compendium in drug‐facilitated sexual assault cases

Journal of Forensic Sciences, EarlyView.
Abstract Drug‐facilitated sexual assault (DFSA) may involve a diverse array of substances, including illicit drugs, prescription medications, and over‐the‐counter pharmaceuticals. Hair analysis has emerged as a valuable forensic tool, offering an extended window of detection spanning several months. However, interpreting drug concentrations in hair can
Amandine Fort, Coralie Boudin, Hélène Eysseric‐Guerin, Virginie Scolan, Jérémy Borges, François Chiron, Pierre Henry, Françoise Stanke‐Labesque, Théo Willeman   +8 more
wiley   +1 more source

Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database. [PDF]

Int Clin Psychopharmacol, 2023
Kane JM, Chen A, Lim S, Mychaskiw MA, Tian M, Wang Y, Suett M, Rubio JM.   +7 more
europepmc   +1 more source

Long‐term regular follow‐up yields important benefits in forensic psychiatric patients with psychosis: A 2‐year longitudinal study on psychopathology, general health, quality of life, and functioning

Journal of Forensic Sciences, EarlyView.
Abstract Forensic psychiatric patients often present with severe psychopathology, functional impairment, and poor quality of life. Longitudinal follow‐up studies in forensic psychiatric outpatient populations remain limited. The objective is to assess psychopathology, quality of life, global functioning, and general health in forensic psychiatric ...
Panagiota Bali, Maria Markopoulou, Phoebe Douzenis, Konstantinos Tasios, Emmanouil Rizos, Ioannis Michopoulos, Athanasios Douzenis   +6 more
wiley   +1 more source

Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis. [PDF]

Curr Neuropharmacol, 2023
Yang M, Wang C, Zhao G, Kong D, Liu L, Yuan S, Chen W, Feng C, Li Z.   +8 more
europepmc   +1 more source

Effectiveness of a Psychiatrist‐Led Clinic for Metabolic Health in Severe Mental Illness: A Retrospective Chart Review Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios, Femin Prasad, Riddhita De, Kateryna Maksyutynska, Akash PrasannaKumar, Vittal Korann, Tariq Ahmed, Marcos Sanches, Leah Burton, Mohammed A. Alarabi, Tanner Isinger, Michelle Desanti, Rebecca Oliveira, Daphne J. Korczak, Ariel Graff‐Guerrero, Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal   +17 more
wiley   +1 more source

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia. [PDF]

Ther Adv Psychopharmacol, 2022
Ma CH, Chan HY, Hsieh MH, Liu CC, Liu CM, Hwu HG, Kuo CH, Chen WJ, Hwang TJ.   +8 more
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source